Type
1.
Aswani Y, Saifi S. Atraumatic Main-En-Griffe due to Ulnar Nerve Leprosy. Polish journal of radiology / Polish Medical Society of Radiology [Internet]. 2016;81:1-4. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702610/pdf/poljradiol-81-1.pdf
Type
1.
Rao N, Dogra S, Suneetha S. Global leprosy program: Does it need uniform-multi-drug therapy now? Indian dermatology online journal [Internet]. 2015;6(6):425-7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693359/
Type
1.
Zhang F, Liu H, Chen S, Low H, Sun L, Cui Y, et al. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nature genetics. 2011;43(12):1247-51.
Type
1.
Grzybowski A, Nita M. Leprosy in the Bible. Clinics in dermatology. 2016;34(1):3-7.
Type
1.
Grzybowski A, Sak J, Pawlikowski J, Nita M. Leprosy: Social implications from antiquity to the present. Clinics in dermatology. 2016;34(1):8-10.
Type
1.
Cruz A. Leprosy as a multilayered biosocial phenomenon: The comparison of institutional responses and illness narratives of an endemic disease in Brazil and an imported disease in Portugal. Clinics in dermatology. 2016;34(1):16-23.
Type
1.
Schreuder P, Noto S, Richardus JH. Epidemiologic trends of leprosy for the 21st century. Clinics in dermatology. 2016;34(1):24-31.
Type
1.
Noordeen S. History of chemotherapy of leprosy. Clinics in dermatology. 2016;34(1):32-6.
Type
1.
Naafs B, Hees C. Leprosy type 1 reaction (formerly reversal reaction). Clinics in dermatology. 2016;34(1):37-50.
Type
1.
Garbino JA, Heise CO, Marques W. Assessing nerves in leprosy. Clinics in dermatology. 2016;34(1):51-8.